Breaking News Instant updates and real-time market news.

FCX

Freeport McMoRan

$9.63

-0.03 (-0.31%)

, NOVN

Novan

$18.97

0.31 (1.66%)

10:40
10/17/16
10/17
10:40
10/17/16
10:40

On The Fly: Top five analyst initiations

Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Freeport McMoRan (FCX) reinstated with an Underperform at BofA/Merrill. 2. Novan (NOV) initiated with an Overweight at Piper Jaffray, an Outperform at Wedbush, and an Outperform at JMP Securities. 3. CapStar Financial (CSTR) initiated with a Market Perform at Keefe Bruyette, a Hold at Sandler O'Neill, and an Outperform at Raymond James. 4. Trade Desk (TTD) initiated with a Buy at Jefferies, an Outperform at RBC Capital, a Buy at Citi, a Buy at Needham, and an Outperform at Raymond James. 5. e.l.f. Beauty (ELF) initiated with a Neutral at JPMorgan, an Overweight at Piper Jaffray, a Market Perform at Wells Fargo, an Outperform at William Blair, a Hold at Stifel, a Buy at SunTrust, an Outperform at Cowen, and an Equal Weight at Morgan Stanley. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.

FCX

Freeport McMoRan

$9.63

-0.03 (-0.31%)

NOVN

Novan

$18.97

0.31 (1.66%)

CSTR

CapStar Financial

$17.73

0.03 (0.17%)

TTD

Trade Desk

$26.36

0.39 (1.50%)

ELF

e.l.f. Beauty

$27.16

0.22 (0.82%)

  • 25

    Oct

  • 28

    Oct

  • 06

    Nov

  • 29

    Nov

FCX Freeport McMoRan
$9.63

-0.03 (-0.31%)

10/17/16
BOFA
10/17/16
INITIATION
BOFA
Underperform
Freeport McMoRan reinstated with an Underperform at BofA/Merrill
BofA/Merrill analyst Timna Tanners reinstated coverage on Freeport McMoRan with an Underperform and an $8 price target. The BofA/Merill global commodity team sees copper among the weakest base metals against a backdrop of sluggish global growth and large mines coming online. Tanners said Indonesia mine risk will be a focus as export restrictions could start in 2017 and its unclear what will happen when Freeport McMoRan's license expires in 2021.
10/03/16
DBAB
10/03/16
UPGRADE
DBAB
Buy
Barrick, Freeport, Pan American upgraded to Buy at Deutsche Bank
Deutsche Bank analyst Jorge Beristain noted that while commodity prices rallied in Q3 Metals & Mining companies continued to get their "financial houses in order" and he expects the trend to continue for the next few quarters. The analyst, who recommends investing in non-integrated companies as well as building Precious exposure, is upgrading several stocks in the sector, including Barrick Gold (ABX), Freeport McMoRan (FCX), Pan American Silver (PAAS), all to Buy from Hold. The analyst also upgraded a number of others in the sector to Hold from Sell this morning.
10/03/16
10/03/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Dow Chemical (DOW) and DuPont (DD) were upgraded to Buy from Neutral at Citi with analyst P.J. Juvekar citing he opportunity presented by the proposed merger. 2. Freeport McMoRan (FCX), Barrick Gold (ABX), and Pan American Silver (PAAS) were upgraded to Buy from Hold at Deutsche Bank. 3. LogMeln (LOGM) upgraded to Overweight from Equal Weight at Barclays with analyst Raimo Lenschow saying the pending merger with Citrix's (CTXS) divested GoTo assets creates a "great new opportunity." 4. Halliburton (HAL) upgraded to Buy from Hold at Societe General. 5. Coty (COTY) upgraded to Buy from Neutral at BofA/Merrill with analyst Olivia Tong saying she believes Coty is at the beginning of a potential transformation with the pending closure of the P&G Beauty deal this week that could bring increased scale as well as a more targeted operational structure. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/13/16
DBAB
10/13/16
UPGRADE
Target $77
DBAB
Buy
Anadarko upgraded to Buy from Hold at Deutsche Bank
Deutsche Bank analyst Ryan Todd upgraded Anadarko Petroleum (APC) to Buy saying the company's Freeport McMoRan (FCX) transaction is "highly attractive" and addressed his primary concerns around its funding profile, growth and leverage. The analyst believes Anadarko's U.S. onshore assets are "best-in-class." Todd keeps a $77 price target for the shares.
NOVN Novan
$18.97

0.31 (1.66%)

10/17/16
JMPS
10/17/16
INITIATION
JMPS
Outperform
Novan initiated with an Outperform at JMP Securities
Analyst Donald Ellis started Novan with an Outperform rating and a $31 price target.
10/17/16
WEDB
10/17/16
INITIATION
Target $27
WEDB
Outperform
Novan initiated with an Outperform at Wedbush
Wedbush analyst David Nierengarten initiated Novan with an Outperform and a $27price target saying the company is expected to experience major near-term catalysts, including Ph 3 readout of SB204 in acne in 1Q17 and Ph 2 SB206 data in genital warts by YE16. The analyst expects SB204's differentiated profile to result in a first pass approval in late 2018 and launch soon after and SB206 data to support further development.
10/17/16
PIPR
10/17/16
INITIATION
Target $25
PIPR
Overweight
Novan initiated with an Overweight at Piper Jaffray
Piper Jaffray analyst David Amsellem started Novan with an Overweight rating and $25 price target. The analyst believes the company's Nitricil platform in medical dermatology has the potential to "drive transformative longer-term value creation."
CSTR CapStar Financial
$17.73

0.03 (0.17%)

09/22/16
COMP
09/22/16
INITIATION
Target $19
COMP
Buy
CapStar Financial initiated with a Buy at Compass Point
Compass Point analyst Laurie Havener Hunsicker initiated CapStar Financial with $19 price target. CapStar priced a 2.9M share IPO at $15 today. The analyst said CapStar trades at a discount to peers, is "whistle clean," high-growth community bank, with a commercial focus, in one of the most desirable and fastest growing markets in the Southeast.
10/17/16
SDLR
10/17/16
INITIATION
Target $19
SDLR
Hold
CapStar Financial initiated with a Hold at Sandler O'Neill
Sandler O'Neill analyst Stephen Scouten started CapStar Financial with a Hold rating and $19 price target.
10/17/16
RAJA
10/17/16
INITIATION
Target $20
RAJA
Outperform
CapStar Financial initiated with an Outperform at Raymond James
Raymond James analyst Daniel Cardenas started CapStar Financial with an Outperform rating and $20 price target.
10/17/16
KBWI
10/17/16
INITIATION
Target $19
KBWI
Market Perform
CapStar Financial initiated with a Market Perform at Keefe Bruyette
Keefe Bruyette analyst Catherine Mealor started CapStar Financial with a Market Perform rating and $19 price target.
TTD Trade Desk
$26.36

0.39 (1.50%)

10/17/16
SBSH
10/17/16
INITIATION
Target $31
SBSH
Buy
Trade Desk initiated with a Buy at Citi
Citi analyst Mark Kelley started Trade Desk with a Buy rating and $31 price target. The analyst views the company's guidance as overly conservative and sees additional upside despite the 46% rally since the stock began trading on September 21.
10/17/16
NEED
10/17/16
INITIATION
Target $32
NEED
Trade Desk initiated with a Buy at Needham
Needham analyst Kerry Rice initiated Trade Desk with a Buy and a $32 price target.
10/17/16
RAJA
10/17/16
INITIATION
Target $31
RAJA
Outperform
Trade Desk initiated with an Outperform at Raymond James
Raymond James analyst Aaron Kessler initiated Trade Desk with an Outperform and a $31 price target given a large and growing programmatic advertising market, strong technology, expectations for 20% plus long-term revenue growth, and scalable software-like model driving high margin expansion.
10/17/16
RBCM
10/17/16
INITIATION
Target $33
RBCM
Outperform
Trade Desk initiated with an Outperform at RBC Capital
RBC Capital analyst Mark Mahaney started Trade Desk with an Outperform rating and $33 price target.
ELF e.l.f. Beauty
$27.16

0.22 (0.82%)

10/17/16
COWN
10/17/16
INITIATION
Target $32
COWN
Outperform
e.l.f. Beauty initiated with an Outperform at Cowen
Cowen analyst Oliver Chen initiated e.l.f Beauty with an Outperform and a $32 price target.
10/17/16
MSCO
10/17/16
INITIATION
Target $28
MSCO
Equal Weight
e.l.f. Beauty initiated with an Equal Weight at Morgan Stanley
Morgan Stanley analyst Dara Mohsenian initiated e.l.f. Beauty with an Equal Weight and a $28 price target saying valuation reflect the company's growth outlook.
10/17/16
RHCO
10/17/16
INITIATION
Target $32
RHCO
Buy
e.l.f. Beauty initiated with a Buy at SunTrust
SunTrust analyst William Chappell initiated e.l.f Beauty with a Buy and a $32 price target.
10/17/16
STFL
10/17/16
INITIATION
Target $25
STFL
Hold
e.l.f. Beauty initiated with a Hold at Stifel
Stifel analyst Mark Astrachan initiated e.l.f Beauty with a Hold and a $25 price target due to valuation.

TODAY'S FREE FLY STORIES

CELG

Celgene

$117.63

-1.24 (-1.04%)

22:25
12/04/16
12/04
22:25
12/04/16
22:25
Conference/Events
Celgene to hold an analyst and investor event »

Management holds an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Dec

  • 06

    Dec

AAPL

Apple

$109.90

0.41 (0.37%)

, ALNY

Alnylam

$41.57

-0.01 (-0.02%)

21:48
12/04/16
12/04
21:48
12/04/16
21:48
Hot Stocks
On The Fly: Top five weekend stock stories »

Catch up on the…

AAPL

Apple

$109.90

0.41 (0.37%)

ALNY

Alnylam

$41.57

-0.01 (-0.02%)

BLCM

Bellicum Pharmaceuticals

$18.72

1.74 (10.25%)

SGEN

Seattle Genetics

$66.70

-0.01 (-0.01%)

CELG

Celgene

$117.63

-1.24 (-1.04%)

UTX

United Technologies

$108.22

0.74 (0.69%)

RXN

Rexnord

$20.27

-0.72 (-3.43%)

ETP

Energy Transfer Partners

$34.38

1.16 (3.49%)

EVC

Entravision

TJX

TJX

$77.10

-0.57 (-0.73%)

FL

Foot Locker

$74.23

0.55 (0.75%)

DE

Deere

$101.50

-1.2 (-1.17%)

ARCH

Arch Coal

$79.32

1.6 (2.06%)

ELY

Callaway Golf

$11.68

-0.3 (-2.50%)

GME

GameStop

$24.27

-0.37 (-1.50%)

AEO

American Eagle

$16.17

-0.57 (-3.41%)

JCP

J.C. Penney

$9.81

0.28 (2.94%)

GOOG

Alphabet

$750.50

2.58 (0.34%)

GOOGL

Alphabet Class A

$764.46

0.13 (0.02%)

MRK

Merck

$61.13

0.37 (0.61%)

DIS

Disney

$98.50

-0.44 (-0.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Dec

  • 05

    Dec

  • 05

    Dec

  • 05

    Dec

  • 06

    Dec

  • 09

    Jan

  • 15

    Jan

  • 08

    Mar

  • 13

    Mar

TRIP

TripAdvisor

$46.46

-0.7 (-1.48%)

21:40
12/04/16
12/04
21:40
12/04/16
21:40
Upgrade
TripAdvisor rating change  »

TripAdvisor upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CTXS

Citrix

$85.62

0.15 (0.18%)

21:40
12/04/16
12/04
21:40
12/04/16
21:40
Upgrade
Citrix rating change  »

Citrix upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 07

    Dec

  • 08

    Dec

XOM

Exxon Mobil

$87.04

-0.2 (-0.23%)

21:12
12/04/16
12/04
21:12
12/04/16
21:12
Periodicals
Trump widens Secretary of State search, will interview Exxon Mobil CEO, WSJ says »

President-elect Donald…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

NVS

Novartis

$68.17

0.42 (0.62%)

, JNJ

Johnson & Johnson

$111.96

0.58 (0.52%)

21:08
12/04/16
12/04
21:08
12/04/16
21:08
Periodicals
Novartis CEO downplays possibility of Actelion bid, Reuters says »

Asked whether Novartis…

NVS

Novartis

$68.17

0.42 (0.62%)

JNJ

Johnson & Johnson

$111.96

0.58 (0.52%)

ALIOF

Actelion

$206.01

15.21 (7.97%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

PCRFY

Panasonic

$10.58

0.19 (1.83%)

21:05
12/04/16
12/04
21:05
12/04/16
21:05
Periodicals
Panasonic eyes European headlight maker ZKW, Nikkei says »

Panasonic plans to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$109.90

0.41 (0.37%)

21:03
12/04/16
12/04
21:03
12/04/16
21:03
Hot Stocks
Apple comments on U.S. autonomous cars policy, says 'excited' about potential »

The U.S.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Mar

ETP

Energy Transfer Partners

$34.38

1.16 (3.49%)

20:46
12/04/16
12/04
20:46
12/04/16
20:46
Hot Stocks
Army says will not grant easement for Dakota Access Pipeline »

The Department of the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INCY

Incyte

$102.02

2.09 (2.09%)

, PFE

Pfizer

$31.63

0.17 (0.54%)

20:25
12/04/16
12/04
20:25
12/04/16
20:25
Conference/Events
Canaccord biotech analyst to hold a dinner meeting »

In conjunction with the…

INCY

Incyte

$102.02

2.09 (2.09%)

PFE

Pfizer

$31.63

0.17 (0.54%)

LLY

Eli Lilly

$67.71

1.74 (2.64%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Dec

  • 06

    Dec

  • 15

    Dec

AGIO

Agios Pharmaceuticals

$56.97

-1.09 (-1.88%)

20:11
12/04/16
12/04
20:11
12/04/16
20:11
Hot Stocks
Agios Pharmaceuticals reports data on AG-348, AG-519 »

Agios Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Dec

KPTI

Karyopharm

$9.28

0.25 (2.77%)

19:59
12/04/16
12/04
19:59
12/04/16
19:59
Hot Stocks
Karyopharm reports updated Phase 2b STORM data »

Karyopharm Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

JNJ

Johnson & Johnson

$111.96

0.58 (0.52%)

, ABBV

AbbVie

$59.43

0.27 (0.46%)

19:56
12/04/16
12/04
19:56
12/04/16
19:56
Hot Stocks
AbbVie reports data from two IMBRUVICA combination studies »

AbbVie (ABBV) announced…

JNJ

Johnson & Johnson

$111.96

0.58 (0.52%)

ABBV

AbbVie

$59.43

0.27 (0.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 06

    Dec

BPMC

Blueprint Medicines

$27.01

-0.99 (-3.54%)

19:50
12/04/16
12/04
19:50
12/04/16
19:50
Hot Stocks
Blueprint Medicines reports Phase 1 BLU-285 data »

Blueprint Medicines…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

INCY

Incyte

$102.02

2.09 (2.09%)

19:45
12/04/16
12/04
19:45
12/04/16
19:45
Hot Stocks
Incyte reports pooled analysis of five-year Jakafi data »

Incyte announced an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Dec

GPRO

GoPro

$9.70

-0.12 (-1.22%)

19:42
12/04/16
12/04
19:42
12/04/16
19:42
Hot Stocks
GoPro releases $299 'Karma Grip' camera stabilizer »

GoPro announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 07

    Dec

  • 12

    Dec

KPTI

Karyopharm

$9.28

0.25 (2.77%)

19:37
12/04/16
12/04
19:37
12/04/16
19:37
Hot Stocks
Karyopharm reports data from Phase 2 SAIL study »

Karyopharm Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

CELG

Celgene

$117.63

-1.24 (-1.04%)

19:32
12/04/16
12/04
19:32
12/04/16
19:32
Hot Stocks
Acetylon reports preclinical ACY-957 data »

Acetylon Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Dec

  • 06

    Dec

GBT

Global Blood Therapeutics

$19.10

-0.1 (-0.52%)

19:30
12/04/16
12/04
19:30
12/04/16
19:30
Hot Stocks
Global Blood Therapeutics reports Phase 1/2 GBT440 data »

Global Blood Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Dec

  • 05

    Dec

  • 14

    Dec

  • 15

    Dec

  • 19

    Dec

CELG

Celgene

$117.63

-1.24 (-1.04%)

19:27
12/04/16
12/04
19:27
12/04/16
19:27
Hot Stocks
Acetylon reports initial Phase 1a/b data for citarinostat in myeloma »

Acetylon Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Dec

  • 06

    Dec

XLRN

Acceleron

$36.29

1.25 (3.57%)

, CELG

Celgene

$117.63

-1.24 (-1.04%)

19:23
12/04/16
12/04
19:23
12/04/16
19:23
Hot Stocks
Acceleron, Celgene report updated data from Phase 2 luspatercept studies »

Acceleron Pharma (XLRN)…

XLRN

Acceleron

$36.29

1.25 (3.57%)

CELG

Celgene

$117.63

-1.24 (-1.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Dec

  • 04

    Dec

  • 05

    Dec

  • 06

    Dec

ALNY

Alnylam

$41.57

-0.01 (-0.02%)

19:05
12/04/16
12/04
19:05
12/04/16
19:05
Hot Stocks
Alnylam reports Phase 2 data on fitusiran in hemophilia »

Alnylam Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALXN

Alexion

$122.96

0.95 (0.78%)

19:01
12/04/16
12/04
19:01
12/04/16
19:01
Hot Stocks
Alexion reports data from Phase 1/2 ALXN1210 study »

Alexion Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 14

    Dec

LYV

Live Nation

$27.07

-0.44 (-1.60%)

18:58
12/04/16
12/04
18:58
12/04/16
18:58
Hot Stocks
Live Nation acquires 51% stake in Australia's Secret Sounds Group »

Live Nation Entertainment…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVS

Novartis

$68.17

0.42 (0.62%)

18:45
12/04/16
12/04
18:45
12/04/16
18:45
Hot Stocks
Novartis reports Phase 2 data on CTL019 in leukemia »

Novartis announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.